The DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.
Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis
Open accessAbstract
Background & aims Primary sclerosing cholangitis (PSC) is an orphan hepatobiliary disorder associated with inflammatory bowel disease (IBD). We aimed to estimate the risk of disease progression based on distinct clinical phenotypes in a large international cohort of patients with PSC.Methods We performed a retrospective outcome analysis of patients diagnosed with PSC from 1980 through 2010 at 37 centers in Europe, North America, and Australia. For each patient, we collected data on sex, clinician-reported age at and date of PSC and IBD diagnoses, phenotypes of IBD and PSC, and date and indication of IBD-related surgeries. The primary and secondary endpoints were liver transplantation or death (LTD) and hepatopancreatobiliary malignancy, respectively. Cox proportional hazards models were applied to determine the effects of individual covariates on rates of clinical events, with time-to-event analysis ascertained through Kaplan-Meier estimates.Results Of the 7121 patients in the cohort, 2616 met the primary endpoint (median time to event of 14.5 years) and 721 developed hepatopancreatobiliary malignancy. The most common malignancy was cholangiocarcinoma (n = 594); patients of advanced age at diagnosis had an increased incidence compared with younger patients (incidence rate: 1.2 per 100 patient-years for patients younger than 20 years old, 6.0 per 100 patient-years for patients 21-30 years old, 9.0 per 100 patient-years for patients 31-40 years old, 14.0 per 100 patient-years for patients 41-50 years old, 15.2 per 100 patient-years for patients 51-60 years old, and 21.0 per 100 patient-years for patients older than 60 years). Of all patients with PSC studied, 65.5% were men, 89.8% had classical or large-duct disease, and 70.0% developed IBD at some point. Assessing the development of IBD as a time-dependent covariate, Crohn's disease and no IBD (both vs ulcerative colitis) were associated with a lower risk of LTD (unadjusted hazard ratio [HR], 0.62; P < .001 and HR, 0.90; P = .03, respectively) and malignancy (HR, 0.68; P = .008 and HR, 0.77; P = .004, respectively). Small-duct PSC was associated with a lower risk of LTD or malignancy compared with classic PSC (HR, 0.30 and HR, 0.15, respectively; both P < .001). Female sex was also associated with a lower risk of LTD or malignancy (HR, 0.88; P = .002 and HR, 0.68; P < .001, respectively). In multivariable analyses assessing the primary endpoint, small-duct PSC characterized a low-risk phenotype in both sexes (adjusted HR for men, 0.23; P < .001 and adjusted HR for women, 0.48; P = .003). Conversely, patients with ulcerative colitis had an increased risk of liver disease progression compared with patients with Crohn's disease (HR, 1.56; P < .001) or no IBD (HR, 1.15; P = .002).Conclusions In an analysis of data from individual patients with PSC worldwide, we found significant variation in clinical course associated with age at diagnosis, sex, and ductal and IBD subtypes. The survival estimates provided might be used to estimate risk levels for patients with PSC and select patients for clinical trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The close relationship with IBD is likely relevant, as shown by variable disease behaviour depending on the clinical presentation of IBD.6,8”
From EASL Clinical Practice Guidelines on sclerosing cholangitis (2022) · cites this paper as [6]
In the citing paper
“An important feature of PSC is the inherent risk of neoplasia at the affected mucosal surfaces, most commonly in the form of cholangiocarcinoma (CCA) and colorectal cancer.[5][6][7]”
From EASL Clinical Practice Guidelines on sclerosing cholangitis (2022) · cites this paper as [6]
In the citing paper
“CCA is very rarely seen in patients with small duct PSC.6”
From EASL Clinical Practice Guidelines on sclerosing cholangitis (2022) · cites this paper as [6]
In the citing paper
“most people with PSC have benign strictures leading to end-stage disease and will not develop hepatobiliary malignancy.6”
From EASL Clinical Practice Guidelines on sclerosing cholangitis (2022) · cites this paper as [6]
In the citing paper
“Data supporting that IBD (and its inflammatory activity) is important for PSC progression is that UC, as opposed to no IBD 368 or Crohns disease, is associated with faster PSC progression.6”
From EASL Clinical Practice Guidelines on sclerosing cholangitis (2022) · cites this paper as [6]
In the citing paper
“In a large, multicentre international retrospective study including 781 children and young people diagnosed with PSC, 67% fulfilled the diagnostic criteria for AIH, in contrast to 6.6% in a similar study including 7,121 adults, suggesting higher prevalence in the paediatric population.6,427”
From EASL Clinical Practice Guidelines on sclerosing cholangitis (2022) · cites this paper as [6]
In the citing paper
“In the retrospective outcome analysis of patients diagnosed with PSC from 1980 through 2010 at 37 centres in Europe, North America, and Australia including 7,121 patients, the incidence of CCA in 940 patients < -20 years-old was 1.2/100 patient-years increasing with age to 21/100 patientyears for those over the age of 60. 6”
From EASL Clinical Practice Guidelines on sclerosing cholangitis (2022) · cites this paper as [6]
In the citing paper
“Patients with associated UC were at higher risk of developing CCA.”
From EASL Clinical Practice Guidelines on sclerosing cholangitis (2022) · cites this paper as [6]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Contributions to Probability and Statistics: Essays in Honor of Harold Hotelling.
David, F. N., Olkin, I., Ghurye, S. G., Hoeffding, W., Madow, W. G., & Mann, H. B. (1961) · Journal of the Royal Statistical Society Series A (General) · doi:10.2307/2984135 · Cited by 1,914
EASL Clinical Practice Guidelines: management of cholestatic liver diseases
European Association for the Study of the Liver (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.04.009 · Cited by 1,729
Assche, G. V., Dignass, A. U., Panés, J., Beaugerie, L., Karagiannis, J. A., Allez, M., Ochsenkühn, T., Orchard, T., Rogler, G., Louis, E. J., et al. (2010) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2009.12.003 · Cited by 1,444
Diagnosis and Management of Primary Sclerosing Cholangitis
Chapman, R. W., Fevery, J., Kalloo, A. N., Nagorney, D. M., Boberg, K. M., Shneider, B. L., & Gores, G. J. (2009) · Hepatology · doi:10.1002/hep.23294 · Cited by 1,230
Self-citationDignass, A. U., Eliakim, R., Magro, F., Maaser, C., Chowers, Y., Geboes, K., Mantzaris, G. J., Reinisch, W., Colombel, J., Vermeire, S., et al. (2012) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2012.09.003 · Cited by 903
Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis.
Broomé, U., Olsson, R., Lööf, L., Bodemar, G., Hultcrantz, R., Danielsson, A., Prytz, H., Sandberg–Gertzén, H., Wallerstedt, S. M., & Lindberg, G. (1996) · Gut · doi:10.1136/gut.38.4.610 · Cited by 816
Boonstra, K., Weersma, R. K., van Erpecum, K. J., Rauws, E. A., Spanier, B. W. M., Poen, A. C., van Nieuwkerk, K. M., Drenth, J. P., Witteman, B. J., Tuynman, H. A., et al. (2013) · Hepatology · doi:10.1002/hep.26565 · Cited by 725
Self-citationHigh-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis
Lindor, K. D., Kowdley, K. V., Luketic, V. A. C., Harrison, E. M., McCashland, T., Befeler, A. S., Harnois, D., Jorgensen, R., Petz, J., Keach, J., et al. (2009) · Hepatology · doi:10.1002/hep.23082 · Cited by 720
Self-citationHepatic and extrahepatic malignancies in primary sclerosing cholangitis
Bergquist, A., Ekbom, A., Olsson, R., Kornfeldt, D., Lööf, L., Danielsson, Å., Hultcrantz, R., Lindgren, S., Prytz, H., Sandberg-Gertzén, H., et al. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00288-4 · Cited by 717
Self-citationThirty-Year Analysis of a Colonoscopic Surveillance Program for Neoplasia in Ulcerative Colitis
Rutter, M. D., Saunders, B. P., Wilkinson, K. H., Rumbles, S., Schofield, G., Kamm, M. A., Williams, C. B., Price, A. B., Talbot, I. C., & Forbes, A. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.12.035 · Cited by 645
Flagged first, then by citations
Research works printed but not linked: 6
- Boberg, 2002, Cholangiocarcinoma in primary sclerosing cholangitis: risk factors and clinical presentation, Scand J Gastroenterol, 37, 1205, 10.1080/003655202760373434 · DOI
- Fevery, 2016, Patients with large-duct primary sclerosing cholangitis and Crohn’s disease have a better outcome than those with ulcerative colitis, or without IBD, Aliment Pharmacol Ther, 43, 612, 10.1111/apt.13516 · DOI · Paper page
- Rudolph, 2010, In PSC with dominant bile duct stenosis, IBD is associated with an increase of carcinomas and reduced survival, J Hepatol, 53, 313, 10.1016/j.jhep.2010.02.030 · DOI
- Boonstra, 2013, Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis, Hepatology, 58, 2045, 10.1002/hep.26565 · DOI · Paper page
- Bergquist, 2002, Hepatic and extrahepatic malignancies in primary sclerosing cholangitis, J Hepatol, 36, 321, 10.1016/S0168-8278(01)00288-4 · DOI · Paper page
- Lindor, 2009, High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis, Hepatology, 50, 808, 10.1002/hep.23082 · DOI · Paper page
Cited by
Sorted by citations
Items 301–400 of 534
Berhane, B., van Rheenen, P. F., & Verkade, H. J. (2023) · Health Science Reports · doi:10.1002/hsr2.1086 · Cited by 6
Abramczyk, J., Milkiewicz, M., Huła, B., Milkiewicz, P., & Kempińska‐Podhorodecka, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119175 · Cited by 6
Self-citationIncidence and adverse clinical events of primary sclerosing cholangitis with ulcerative colitis
Han, I. S., Baek, D. H., Hong, S. M., Lee, B. E., Lee, M. W., Kim, G. H., & Song, G. A. (2023) · International Journal of Colorectal Disease · doi:10.1007/s00384-023-04464-z · Cited by 6
Creutzfeldt, A. M., Piecha, F., Schattenberg, J. M., Schramm, C., & Lohse, A. W. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.07.027 · Cited by 6
Self-citationWu, D., Chen, D., Shi, W., Liu, W., Zhou, W., & Qian, J. (2021) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/2021/9936932 · Cited by 6
UEG Week 2018 Oral Presentations
Laursen, S. B., Oakland, K., Laine, L., Bieber, V, Marmo, R., Redondo Cerezo, E., Dalton, H. R., Ngu, J., Schultz, M., Gralnek, I., et al. (2018) · United European Gastroenterology Journal · doi:10.1177/2050640618792817 · Cited by 7
Navigating Neoplasm Risk in Inflammatory Bowel Disease and Primary Sclerosing Cholangitis
Pitoni, D., Buono, A. D., Gabbiadini, R., Ronca, V., Colapietro, F., Pugliese, N., Ribaldone, D. G., Bezzio, C., Lleò, A., & Armuzzi, A. (2025) · Cancers · doi:10.3390/cancers17132165 · Cited by 5
Wang, S., Farokhian, A., & Shen, B. (2025) · eGastroenterology · doi:10.1136/egastro-2025-100199 · Cited by 5
Sex Hormones and the Liver: Implications for Disease Progression and Hormonal Therapy
Cazzagon, N., Gambato, M., Brunetto, M. R., Villa, E., Burra, P., & Floreani, A. (2026) · Liver International · doi:10.1111/liv.70509 · Cited by 6
Self-citationAfonso, A. B., da Silva, C. M., Nogueira, P., & Machado, M. V. (2025) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.70357 · Cited by 5
Mínguez, A., Amiel, I. C., Abia, P. L., Delgado, S. M., Pérez, Á. C., & Berenguer, M. (2021) · Gastroenterología y Hepatología · doi:10.1016/j.gastrohep.2021.03.017 · Cited by 5
Nair, A., Macdonald, D. B., Kelly, E., Satheesh, S., Venugopalan, P., & Soman, D. K. (2021) · Clinical Imaging · doi:10.1016/j.clinimag.2021.08.007 · Cited by 5
Praktiknjo, M., Zhou, T., Krüsken, M., Jacob, T., Sprinkart, A. M., Nowak, S., Kimmann, M., Dold, L., Chang, J., Jansen, C., et al. (2023) · Digestive and Liver Disease · doi:10.1016/j.dld.2023.08.037 · Cited by 5
Self-citationParigi, T. L., Allocca, M., Furfaro, F., D’Amico, F., Zilli, A., Buono, A. D., Gabbiadini, R., Bonovas, S., Armuzzi, A., Danese, S., et al. (2023) · Cancers · doi:10.3390/cancers15245754 · Cited by 5
Huynh, D., Rubtsov, D., & Khaing, M. M. (2024) · Cureus · doi:10.7759/cureus.56182 · Cited by 5
Self-citationGrimsrud, M. M., Förster, M., Goeppert, B. F., Hemmrich‐Stanisak, G., Sax, I., Grzyb, K., Braadland, P. R., Charbel, A., Metzger, C., Albrecht, T., et al. (2024) · Hepatology Communications · doi:10.1097/hc9.0000000000000461 · Cited by 5
Self-citationBarner‐Rasmussen, N., Molinaro, A., Mol, B., Ponsioen, C. Y., Bergquist, A. M., Kautiainen, H., & Färkkilä, M. A. (2025) · Endoscopy · doi:10.1055/a-2511-3422 · Cited by 5
Self-citationUpdate in the Care and Management of Patients with Primary Sclerosing Cholangitis
Sedki, M., & Levy, C. (2018) · Current Gastroenterology Reports · doi:10.1007/s11894-018-0635-8 · Cited by 5
Self-citationChronic cholestatic liver diseases - Primary biliary cholangitis and Primary sclerosing cholangitis
Fejfar, T., Vaňásek, T., & Hůlek, P. (2020) · Vnitřní lékařství · doi:10.36290/vnl.2020.084 · Cited by 5
Azzam, N. A., AlRuthia, Y. S., Alharbi, O., Aljebreen, A., Almadi, M. A., & Loftus, E. V. (2020) · Hepatology International · doi:10.1007/s12072-020-10110-5 · Cited by 5
Diagnosis of Primary Sclerosing Cholangitis Beyond Childhood is Associated with Worse Outcomes
Tica, S., Alghamdi, S. A., Tait, C., Nemera, B., Turmelle, Y. P., Fleckenstein, J., Stoll, J. M., & Kulkarni, S. (2021) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2021.03.006 · Cited by 5
Ceccherini, E., Michelucci, E., Signore, G., Coco, B. A., Zari, M., Bellini, M., Brunetto, M. R., Cecchettini, A., & Rocchiccioli, S. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13020544 · Cited by 5
Daiku, K., Fukuda, K., Morimoto, O., Takiuchi, D., Shimakoshi, H., Kegasawa, T., Yamaguchi, Y., Kogita, S., Sawai, Y., Nakahara, M., et al. (2020) · Clinical Journal of Gastroenterology · doi:10.1007/s12328-020-01204-6 · Cited by 5
Lemoinne, S., Sabino, J., & Sokol, H. (2019) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2019.06.005 · Cited by 5
Mol, B., van Nieuwamerongen, M., van Munster, K. N., Färkkilä, M. A., Folseraas, T., Tjønnfjord, S. K. V., Hov, J. R., Boberg, K. M., Vesterhus, M. N., Jørgensen, K. K., et al. (2025) · JHEP Reports · doi:10.1016/j.jhepr.2025.101700 · Cited by 4
Self-citationLawson, K. L., & Wang, H. L. (2023) · Surgical pathology clinics · doi:10.1016/j.path.2023.04.008 · Cited by 4
Lindqvist, C., Ingre, M., Kechagias, S., Nilsson, E., Molinaro, A., Rorsman, F., & Bergquist, A. M. (2024) · Liver International · doi:10.1111/liv.16182 · Cited by 4
Self-citationElzubeir, A., High, J., Hammond, M., Shepstone, L., Pond, M., Walmsley, M., Trivedi, P. J., Culver, E. L., Aithal, G. P., Dyson, J. K., et al. (2025) · BMJ Open Gastroenterology · doi:10.1136/bmjgast-2024-001596 · Cited by 4
Self-citationBuhot, Q., Bui, Q., Chekir, H., Delalandre, C., Mouhadi, S. E., Vanderbecq, Q., Wagner, M., & Arrivé, L. (2025) · European Radiology · doi:10.1007/s00330-025-11606-0 · Cited by 4
Grikyte, I., & Ignatavičius, P. (2025) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-025-03678-9 · Cited by 4
Garg, A., Moond, V., Garg, A., Bassi, M., Mohan, B. P., Broder, A., & Adler, D. G. (2025) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2025.08.028 · Cited by 5
Levers, A., Pantke, J., Klimeš, F., Lenzen, H., Düx, D. M., Taubert, R., Wedemeyer, H. H., Wacker, F. K., & Ringe, K. I. (2025) · Liver International · doi:10.1111/liv.70328 · Cited by 4
Self-citationKulkarni, S., Bhimaniya, S., Chi, L., Tica, S., Alghamdi, S. A., Stoll, J. M., Caudill, K., & Fleckenstein, J. (2023) · Clinical Imaging · doi:10.1016/j.clinimag.2023.01.012 · Cited by 4
Lee, D. U., Menegas, S., Lee, K. J., Pu, A., Bhowmick, K., Ponder, R. D., Fan, G. H., Chou, H., Lee, K., & Urrunaga, N. H. (2023) · Digestive Diseases and Sciences · doi:10.1007/s10620-023-08023-y · Cited by 4
Maternal liver-related symptoms during pregnancy in primary sclerosing cholangitis
Nayagam, J. S., Weismüller, T. J., Milkiewicz, P., Wronka, K. M., Bik, E., Schramm, C., Fuessel, K., Zhou, T., Chang, J., Färkkilä, M. A., et al. (2023) · JHEP Reports · doi:10.1016/j.jhepr.2023.100951 · Cited by 5
Self-citationLee, D. U., Harmacinski, A., Kolachana, S., Bahadur, A., Lee, K., Lee, K. J., Pu, A., Chou, H., Fan, G. H., & Malik, R. (2024) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000002712 · Cited by 4
Good long-term outcomes of primary sclerosing cholangitis in childhood
Skarby, A. J., Casswall, T., Bergquist, A. M., & Lindström, L. (2024) · JHEP Reports · doi:10.1016/j.jhepr.2024.101123 · Cited by 4
Self-citationLevy, C., Caldwell, S. H., Mantry, P., Luketic, V. A., Landis, C. S., Huang, J., Mena, E., Maheshwari, R., Rank, K. M., Xu, J., et al. (2024) · Clinical and Translational Gastroenterology · doi:10.14309/ctg.0000000000000744 · Cited by 5
Self-citationMetal, magnet or transplant: options in primary sclerosing cholangitis with stricture
Ahmad, J. (2018) · Hepatology International · doi:10.1007/s12072-018-9906-6 · Cited by 4
Geoepidemiologic variation in outcomes of primary sclerosing cholangitis
Mehta, T. I., Weissman, S. I., Fung, B. M., & Tabibian, J. H. (2020) · World Journal of Hepatology · doi:10.4254/wjh.v12.i4.116 · Cited by 4
Primary sclerosing cholangitis and inflammatory bowel disease: a complicated yet unique relationship
Peviani, M., Cazzagon, N., Gambato, M., Bertin, L., Zingone, F., SAVARINO, E. V., & Barberio, B. (2024) · Minerva Gastroenterology · doi:10.23736/s2724-5985.23.03605-7 · Cited by 5
Figueroa, P. N., Muñoz, R. S., Pino, R. Q., Carrasco-Aviño, G., O’Brien, A., & Barril, J. B. (2020) · Revista Española de Enfermedades Digestivas · doi:10.17235/reed.2020.6938/2020 · Cited by 4
Open challenges in the management of autoimmune hepatitis
Gerussi, A., Halliday, N., Carbone, M., Invernizzi, P., & Thorburn, D. (2020) · Minerva Gastroenterology · doi:10.23736/s1121-421x.20.02805-6 · Cited by 5
Self-citationSchramm, C. (2019) · Digestive Diseases and Sciences · doi:10.1007/s10620-019-05927-6 · Cited by 5
Self-citationIs it time to spit? More evidence for the oral–gut–liver axis in liver disease
Acharya, C., & Bajaj, J. S. (2021) · Hepatology International · doi:10.1007/s12072-021-10136-3 · Cited by 4
Primary Sclerosing Cholangitis
Vesterhus, M. N., & Karlsen, T. H. (2019) · Wiley eBooks · doi:10.1002/9781119211419.ch40 · Cited by 4
Self-citationFererberger, T., Buechler, C., Kandulski, A., Elger, T., Loibl, J., Schmid, S. A., Sommersberger, S., Gunawan, S., Zundler, S., Huss, M., et al. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1334865 · Cited by 3
Bergquist, A. M., Kachru, N., Aldvén, M., Ström, O., Skröder, H., Grip, E. T., & Hagström, H. (2025) · Hepatology Communications · doi:10.1097/hc9.0000000000000858 · Cited by 3
Self-citationde Jong, M. J., Zhou, J., Derikx, L. A. A. P., Murad, S. D., van der Meer, A. J., & de Vries, A. C. (2026) · Transplantation · doi:10.1097/tp.0000000000005607 · Cited by 3
Leung, K. K., Li, W., Hansen, B. E., Gulamhusein, A. F., Lapointe‐Shaw, L., Ricciuto, A., Benchimol, E. I., Flemming, J. A., & Hirschfield, G. M. (2026) · Hepatology · doi:10.1097/hep.0000000000001692 · Cited by 3
Self-citationDistinct phenotype of primary sclerosing cholangitis-associated inflammatory bowel disease
Okada, H., Sugimoto, S., Kayashima, A., Mikami, Y., Kanai∥, T., Nakamoto, N., Collaborators, K. P., Yoshimatsu, Y., Kiyohara, H., Nakadai, Y., et al. (2026) · Journal of Gastroenterology · doi:10.1007/s00535-026-02388-3 · Cited by 3
Wohl, P., Krausová, A., Wohl, P., Fabián, O., Bajer, L., Březina, J., Drastich, P., Hlavatý, M., Novotná, P., Kahle, M., et al. (2024) · World Journal of Gastrointestinal Endoscopy · doi:10.4253/wjge.v16.i11.607 · Cited by 3
Crescente, J. G., Dellavance, A., Diniz, M. A., Carrilho, F. J., Andrade, L. E. C., & Cançado, E. L. R. (2021) · Clinics · doi:10.6061/clinics/2021/e2228 · Cited by 3
Primary sclerosing cholangitis in children with inflammatory bowel disease
Usoltseva, O. V., Surkov, A. N., Movsisyan, G. B., Kulebina, E. A., Simersina, S. A., Потапов, А. С., & Lokhmatov, M. M. (2022) · Russian Pediatric Journal · doi:10.46563/1560-9561-2021-24-6-395-404 · Cited by 3
Mínguez, A., Amiel, I. C., Abia, P. L., Delgado, S. M., Pérez, Á. C., & Berenguer, M. (2022) · Gastroenterología y Hepatología (English Edition) · doi:10.1016/j.gastre.2021.03.014 · Cited by 3
Recent Insights into Pediatric Primary Sclerosing Cholangitis
Stevens, J. P., & Gupta, N. A. (2022) · Clinics in Liver Disease · doi:10.1016/j.cld.2022.03.009 · Cited by 9
Gleeson, D. C., Walmsley, M., Trivedi, P. J., Joshi, D., & Rea, B. (2022) · Frontline Gastroenterology · doi:10.1136/flgastro-2022-102172 · Cited by 3
Self-citationBarner‐Rasmussen, N., Sjöblom, N., Arola, J. T., Boyd, S., Kautiainen, H., & Färkkilä, M. A. (2023) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2023.2233038 · Cited by 3
Self-citationElfert, K., Abosheaishaa, H. M., Aboursheid, T., Beran, A., Ahmed, M. F., Musallam, R., & Al-Taee, A. (2023) · Baylor University Medical Center Proceedings · doi:10.1080/08998280.2023.2254196 · Cited by 3
Freitas, L. T. D. S., Hyppólito, E. B., Barreto, V. L., Castelo, L. H. J., Jorge, B. C. D. M., Háteras, F., Marzola, M. B., de Lima, C. A., Celedônio, R. M., Coelho, G., et al. (2023) · World Journal of Hepatology · doi:10.4254/wjh.v15.i9.1033 · Cited by 3
Hussain, N., Ma, C., Hirschfield, G. M., Walmsley, M., Hanford, P., Vesterhus, M. N., Kowdley, K. V., Bergquist, A. M., Ponsioen, C. Y., Levy, C., et al. (2024) · BMJ Open · doi:10.1136/bmjopen-2023-080143 · Cited by 3
Self-citationHorio, R., Kato, J., Taida, T., Ohta, Y., Saito, K., Oyama, Y., Nakazawa, H., Mamiya, Y., Goto, C., Takahashi, S., et al. (2024) · Indian Journal of Gastroenterology · doi:10.1007/s12664-024-01630-1 · Cited by 3
Thorburn, D. (2017) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(17)30296-0 · Cited by 3
Self-citationPolanco, N. A. P., Cottone, C., & Bhamidimarri, K. R. (2020) · Current Hepatology Reports · doi:10.1007/s11901-020-00518-w · Cited by 3
Więcek, S., Wojtyniak, A., Pindur, B., Machnikowska-Sokołowska, M. D., Gruszczyńska, K., & Grzybowska‐Chlebowczyk, U. (2021) · Medicina · doi:10.3390/medicina57070663 · Cited by 3
Sathiaseelan, M., Bolia, R. K., Barallon, R., Alex, G., Hardikar, W., & Rajanayagam, J. (2022) · Journal of Paediatrics and Child Health · doi:10.1111/jpc.15954 · Cited by 3
Risk stratification in primary sclerosing cholangitis
Mulinacci, G., Cristoferi, L., Palermo, A., Luca, M. D., Gerussi, A., Invernizzi, P., & Carbone, M. (2023) · Minerva Gastroenterology · doi:10.23736/s2724-5985.20.02821-4 · Cited by 3
Self-citationSabino, J., & Torres, J. (2018) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14418 · Cited by 3
Thylin, M., Färkkilä, M. A., Kautiainen, H., Barner‐Rasmussen, N., Jokelainen, K., Puustinen, L., Boyd, S., Arola, J. T., & Tenca, A. (2024) · Liver International · doi:10.1111/liv.15985 · Cited by 2
Self-citationFärkkilä, M. A., Åberg, F. O., Alfthan, H. V., Jokelainen, K., Puustinen, L., Kautiainen, H., & Tenca, A. (2024) · JHEP Reports · doi:10.1016/j.jhepr.2024.101161 · Cited by 2
Self-citationZheng, D., Qinke, X., Wu, J., Zhouyue, G., Chen, J., & Liu, Y. (2025) · Gastroenterología y Hepatología (English Edition) · doi:10.1016/j.gastrohep.2025.502346 · Cited by 2
Ultrasound for the Detection of Gallbladder Malignancy in Primary Sclerosing Cholangitis
Altenmüller, J., Wiegard, C., Sebode, M., Lohse, A. W., Villard, C., Kechagias, S., Nilsson, E., Rorsman, F., Marschall, H., Jokelainen, K., et al. (2025) · Liver International · doi:10.1111/liv.70312 · Cited by 2
Self-citationNardelli, M. J., Cançado, G. G. L., Barros, L. L., Dotta, D. D., Faria, L. C., Rotman, V., Villela‐Nogueira, C. A., Ferraz, M. L. G., Rocco, R., Felga, G. E. G., et al. (2025) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000002253 · Cited by 2
Yu, C., Pan, Y., Mao, A., Zhao, Y., Liu, Q., & Hu, Y. (2025) · Biomedicines · doi:10.3390/biomedicines13112659 · Cited by 2
Voulgaris, T. A., Fotios, F., Mousourakis, K., Euaggelos, C., Konstantinos, A., George, M., Konsantinos, T., Fytili, P., Michopoulos, S., Nikoletta, M., et al. (2026) · Digestive and Liver Disease · doi:10.1016/j.dld.2026.01.009 · Cited by 2
Ibrahim, A., & Rockey, D. C. (2026) · Digestive Diseases and Sciences · doi:10.1007/s10620-026-09699-8 · Cited by 2
Jalan‐Sakrikar, N., Anwar, A. A., Ali, A., Nasser‐Ghodsi, N., Felzen, A., Huebert, R. C., LaRusso, N. F., & O’Hara, S. P. (2026) · Physiological Reviews · doi:10.1152/physrev.00022.2025 · Cited by 5
Sebode, M., Bantel, H., Baumann, U., Bufler, P., Demir, M., Dold, L., Keitel, V., Klein, R., Kremer, A. E., Jansen, P. L., et al. (2026) · Zeitschrift für Gastroenterologie · doi:10.1055/a-2769-2475 · Cited by 2
Self-citationThe Role of Cholangioscopy in the Management of Primary Sclerosing Cholangitis
Montaño‐Loza, A. J., Ebadi, M., & Sandha, G. S. (2020) · Current Hepatology Reports · doi:10.1007/s11901-020-00514-0 · Cited by 2
Neoplastic risk for liver and colon in primary sclerosing cholangitis
Båve, A. L., & Bergquist, A. M. (2021) · Hepatoma Research · doi:10.20517/2394-5079.2021.27 · Cited by 2
Self-citationAssociation of serum IgG4 and disease outcomes in patients with inflammatory bowel disease
Chase, R. C. (2023) · Annals of Gastroenterology · doi:10.20524/aog.2023.0807 · Cited by 2
Cho, J. M., Koh, J. H., Kim, S. G., Lee, S., Kim, Y., Cho, S., Kim, K., Kim, Y. C., Han, S. S., Lee, H., et al. (2023) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.16355 · Cited by 2
Primær skleroserende kolangitt
Helgadóttir, H., Folseraas, T., Kemmerich, G., Aabakken, L., Jørgensen, K. K., & Vesterhus, M. N. (2023) · Tidsskrift for Den norske legeforening · doi:10.4045/tidsskr.23.0156 · Cited by 2
Mandea, M., Oancea, D., Ghioca, M. C., Iacob, S. M., Iacob, R. A., Lupescu, I. G., & Gheorghe, L. S. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14165915 · Cited by 2
Ven, P. L., Tornai, D., Toth, B., Vitális, Z., Tornai, I., Tornai, T., Pár, G., & Papp, M. (2025) · Diagnostics · doi:10.3390/diagnostics15172166 · Cited by 2
Nayagam, J. S., Mandour, M. O., Taylor, A., Heneghan, M. A., Dubois, P. C. A., Hayee, B., Lee, H. M., Vadamalayan, B., Samyn, M., Joshi, D., et al. (2022) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2022.101980 · Cited by 2
Hepatobiliary Manifestation of Inflammatory Bowel Disease
Seo, K. I., & Kang, S. (2019) · Korean Journal of Gastroenterology · doi:10.4166/kjg.2019.73.5.248 · Cited by 2
Tissue factor in ulcerative colitis, with and without concomitant primary sclerosing cholangitis
Vessby, J., Lampinen, M., Åberg, M., Rorsman, F., Siegbahn, A. G., Wanders, A., & Carlson, M. (2019) · Upsala Journal of Medical Sciences · doi:10.1080/03009734.2019.1689209 · Cited by 2
Montaño‐Loza, A. J., Allegretti, J. R., Cheung, A., Ebadi, M., Jones, D. E., Kerkar, N. N., Levy, C., Rizvi, S. H., Vierling, J. M., Álvarez, F., et al. (2021) · Canadian Liver Journal · doi:10.3138/canlivj-2021-0006 · Cited by 3
Self-citationBourdeleau, P., Larrey, E., Allaire, M., Charlotte, F., Vaillant, J. C., & Lebray, P. (2021) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2021.101827 · Cited by 2
Hatami, B., Pasharavesh, L., Sharifian, A., & Zali, M. R. (2023) · Gastroenterology and hepatology from bed to bench. · doi:10.22037/ghfbb.v16i2.2589 · Cited by 2
Awoniyi, M., Wang, J., Ngo, B., Meadows, V., Tam, J. W., Viswanathan, A., Lai, Y., Montgomery, S. A., Farmer, M., Kummen, M., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.10.31.466701 · Cited by 2
Self-citationPrimary Sclerosing Cholangitis
Vesterhus, M. N., Beretta‐Piccoli, B. T., Boberg, K. M., & Mieli‐Vergani, G. (2020) · doi:10.1002/9781119532637.ch8 · Cited by 2
Self-citationRisk Stratification in Primary Sclerosing Cholangitis: Does Size Matter?
Hussain, N., & Trivedi, P. J. (2024) · Digestive Diseases and Sciences · doi:10.1007/s10620-023-08262-z · Cited by 2
Self-citationDifferentiating Primary Sclerosing Cholangitis from Similar Diseases of Autoimmune Origin
Kunovský, L., Dítě, P., Horňáková, L., Dolina, J., Uvírová, M., Kojecký, V., Martínek, A., & Jabandžiev, P. (2021) · Journal of Gastrointestinal and Liver Diseases · doi:10.15403/jgld-3849 · Cited by 1
Yu, P.-J., Ho, C., Hsiao, C., Wu, Y., Ho, M., Lee, P., & Hu, R. (2023) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000002516 · Cited by 1
Reconstruction after Colectomy for Inflammatory Bowel Disease
Risto, A. (2023) · Linköping University medical dissertations · doi:10.3384/9789180754002 · Cited by 1
Primary Sclerosing Cholangitis: Gender Effects in Valencia’s Low-Prevalence Region
Mínguez, A., Conde, I., Montón, C., González, L. G., Pascual, S., Antón, M. D., Palau, A., Forés, A., Gisbert, C., Ojeda, A., et al. (2024) · Digestive Diseases and Sciences · doi:10.1007/s10620-024-08368-y · Cited by 1
Tang, Q., Li, L., Li, Y., Yin, W., & Zhong, X. (2024) · Medicine · doi:10.1097/md.0000000000038257 · Cited by 1
Shifman, H. P., Hatchett, J., Pai, R.-A. L., Safer, R., Gomel, R., Vyas, M. P., Li, M., Lai, J. C., & Wadhwani, S. I. (2024) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1002/jpn3.12287 · Cited by 1
Metadata
- Authors
- Weismüller, T. J., Trivedi, P. J., Bergquist, A., Imam, M., Lenzen, H., Ponsioen, C. Y., Holm, K., Gotthardt, D., Färkkilä, M. A., Marschall, H.-U., Thorburn, D., Weersma, R. K., Fevery, J., Mueller, T., Chazouillères, O., Schulze, K., Lazaridis, K. N., Almer, S., Pereira, S. P., Levy, C., Mason, A., Naess, S., Bowlus, C. L., Floreani, A., Halilbasic, E., Yimam, K. K., Milkiewicz, P., Beuers, U., Huynh, D. K., Pares, A., Manser, C. N., Dalekos, G. N., Eksteen, B., Invernizzi, P., Berg, C. P., Kirchner, G. I., Sarrazin, C., Zimmer, V., Fabris, L., Braun, F., Marzioni, M., Juran, B. D., Said, K., Rupp, C., Jokelainen, K., Benito de Valle, M., Saffioti, F., Cheung, A., Trauner, M., Schramm, C., Chapman, R. W., Karlsen, T. H., Schrumpf, E., Strassburg, C. P., Manns, M. P., Lindor, K. D., Hirschfield, G. M., Hansen, B. E., & Boberg, K. M.
- Affiliations
- University of Bonn (DE)
- Queen Elizabeth Hospital Birmingham (GB)
- Karolinska University Hospital (SE)
- Mayo Clinic (US)
- Medizinische Hochschule Hannover (DE)
- Amsterdam UMC Location University of Amsterdam (NL)
- Oslo University Hospital (NO)
- University Hospital Heidelberg (DE)
- University of Helsinki (FI)
- University of Gothenburg (SE)
- The Royal Free Hospital (GB)
- University Medical Center Groningen (NL)
- Universitair Ziekenhuis Leuven (BE)
- Charité – Universitätsmedizin Berlin (DE)
- Assistance Publique – Hôpitaux de Paris (FR)
- University Medical Center Hamburg-Eppendorf (DE)
- Linköping University (SE)
- University College London (GB)
- University of Miami (US)
- University of Alberta (CA)
- University of California, Davis (US)
- University of Padua (IT)
- Medical University of Vienna (AT)
- California Pacific Medical Center (US)
- Medical University of Warsaw (PL)
- Royal Adelaide Hospital (AU)
- University Hospital Zurich (CH)
- University of Calgary (CA)
- University of Milan (IT)
- University of Tübingen (DE)
- University Hospital Regensburg (DE)
- Goethe University Frankfurt (DE)
- Universitätsklinikum des Saarlandes (DE)
- University Hospital Schleswig-Holstein (DE)
- Marche Polytechnic University (IT)
- John Radcliffe Hospital (GB)
- National Institute for Health and Care Research (GB)
- University of Toronto (CA)
- Corresponding author
- Weismüller, Tobias J.
- Boberg, Kirsten M.
- ORCID
- Weismüller, Tobias J.
- Trivedi, Palak J.
- Bergquist, Annika
- Imam, Mohamad
- Lenzen, Henrike
- Ponsioen, Cyriel Y.
- Holm, Kristian
- Gotthardt, Daniel
- Färkkilä, Martti A.
- Marschall, Hanns-Ulrich
- Thorburn, Douglas
- Weersma, Rinse K.
- Fevery, Johan
- Mueller, Tobias
- Chazouillères, Olivier
- Schulze, Kornelius
- Lazaridis, Konstantinos N.
- Almer, Sven
- Pereira, Stephen P.
- Levy, Cynthia
- Mason, Andrew
- Bowlus, Christopher L.
- Floreani, Annarosa
- Halilbasic, Emina
- Milkiewicz, Piotr
- Beuers, Ulrich
- Eksteen, Bertus
- Invernizzi, Pietro
- Berg, Christoph P.
- Zimmer, Vincent
- Fabris, Luca
- Braun, Felix
- Marzioni, Marco
- Said, Karouk
- Rupp, Christian
- Saffioti, Francesca
- Cheung, Angela
- Trauner, Michael
- Schramm, Christoph
- Chapman, Roger W.
- Karlsen, Tom H.
- Strassburg, Christian P.
- Manns, Michael P.
- Lindor, Keith D.
- Hirschfield, Gideon M.
- Hansen, Bettina E.
- Boberg, Kirsten M.
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2017-06
- Volume
- 152
- Issue
- 8
- Pages
- 1975-1984.e8
- ISSN
- 0016-5085 (ISSN-L)
- PMC
- PMC5546611
- OpenAlex
- W2594589478
- Cited by
- 533
- References
- 74
- Citations by year
- 2026: 49 · 2025: 58 · 2024: 60 · 2023: 65 · 2022: 59 · 2021: 68 · 2020: 55 · 2019: 43 · 2018: 49 · 2017: 24
- FWCI
- 28.90
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Gastroenterology (publishedVersion)
- PubMed (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
- PubMed Central (acceptedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- RePub (Erasmus University Rotterdam) (submittedVersion, other-oa)
- BOA (University of Milano-Bicocca) (submittedVersion, other-oa)
- Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona) (submittedVersion, cc-by-nc-nd)
- UCL Discovery (University College London) (submittedVersion)
- University of Regensburg Publication Server (University of Regensburg) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Työväentutkimus Vuosikirja (submittedVersion, other-oa)
- University of Thessaly Institutional Repository (University of Thessaly) (submittedVersion)
- Università Politecnica delle Marche (Università Politecnica delle Marche) (submittedVersion)
- Pure Amsterdam UMC (submittedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion, cc-by-nc-nd)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
- RePub (Erasmus University Rotterdam) (submittedVersion)
- Padua Research Archive (University of Padova) (submittedVersion)
- Funders
- Wellcome Trust
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK084960)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Health Sciences › Medicine › Surgery › Pediatric Hepatobiliary Diseases and Treatments
- Keywords
- primary sclerosing cholangitis, inflammatory bowel disease, cholangiocarcinoma, liver transplantation, disease progression, age at diagnosis, sex differences, Crohn's disease, ulcerative colitis, IBD surgery, mortality
- MeSH terms
- Adult, Australia, Colitis, Ulcerative, Crohn Disease, Europe, Female, Humans, Male, Middle Aged, North America, Phenotype, Prognosis, Retrospective Studies, Risk Factors, Time Factors, Cholangitis, Sclerosing, Incidence, Multivariate Analysis, Chi-Square Distribution, Proportional Hazards Models, Liver Transplantation, Age Distribution, Sex Distribution, Disease Progression, Risk Assessment, Kaplan-Meier Estimate, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
